Aurozyme: A Revolutionary Nanozyme in Colitis, Switching Peroxidase‐Like to Catalase‐Like Activity (Small 41/2023)
Source abstract
Abstract
Aurozymes Aurozyme, a novel nanozyme, effectively treats inflammatory bowel disease (IBD). Composed of gold nanoparticles and glycyrrhizin with a glycol chitosan coating, it scavenges harmful radicals and molecular patterns in colitis. Aurozyme's unique catalase-like activity converts hydroxyl radicals to water and oxygen, reducing inflammation and promoting tissue repair. It also regulates gut microbiota, demonstrating its transformative potential for managing chronic inflammatory conditions. More details can be found in article number 2302331 by Dong Yun Lee and co-workers.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoparticles: synthesis and applications · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Bioengineering College of Engineering, and BK FOUR Biopharmaceutical Innovation Leader for Education and Research Group Hanyang University Seoul 04763 Republic of Korea
Institute of Nano Science and Technology (INST) Hanyang University Seoul 04763 Republic of Korea
Institute for Bioengineering and Biopharmaceutical Research (IBBR) Hanyang University Seoul 04763 Republic of Korea
Elixir Pharmatech Inc. Seoul 07463 Republic of Korea
References
Reference metadata was not supplied for this record.